Journal article
The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure A Network Meta-Analysis
Abstract
TOPIC: To investigate the effect of anti-vascular endothelial growth factor (VEGF) therapy on intraocular pressure (IOP) 12 and 24 months after initiation.
CLINICAL RELEVANCE: It is unclear whether serial anti-VEGF injections result in sustained IOP increases.
Authors
Nanji K; Sarohia GS; Kennedy K; Ceyhan T; McKechnie T; Phillips M; Devji T; Thabane L; Kaiser P; Sarraf D
Journal
Ophthalmology, Vol. 129, No. 5, pp. 498–508
Publisher
Elsevier
Publication Date
5 2022
DOI
10.1016/j.ophtha.2021.11.024
ISSN
0161-6420